M

Mainz Biomed BV
D

MYNZ

1.56000
USD
0.03
(1.96%)
مغلق
حجم التداول
9,735
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
8,444,051
الأخبار المقالات

العنوان: Mainz Biomed N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.